Inactive Instrument

Company Kyowa Hakko Kirin Co Ltd BOERSE MUENCHEN

Equities

Pharmaceuticals

End-of-day quote BOERSE MUENCHEN
- EUR - Intraday chart for Kyowa Hakko Kirin Co Ltd

Business Summary

Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:

- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;

- sales of licenses (7.4%).

At the end of 2021, the group had 3 production sites located in Japan (2) and China.

Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).

Sales per Business

JPY in Million2022Weight2023Weight Delta
Manufactured Product
90.5 %
364,596 91.5 % 400,372 90.5 % +9.81%
Technology
9.5 %
33,775 8.5 % 41,860 9.5 % +23.94%

Sales per region

JPY in Million2022Weight2023Weight Delta
United States
38.9 %
139,852 35.1 % 172,242 38.9 % +23.16%
Japan
34.7 %
154,636 38.8 % 153,462 34.7 % -0.76%
Europe
14.9 %
62,251 15.6 % 65,745 14.9 % +5.61%
Asia
10.1 %
37,368 9.4 % 44,759 10.1 % +19.78%
Americas
1.1 %
4,053 1.0 % 5,054 1.1 % +24.70%
Other
0.2 %
210 0.1 % 972 0.2 % +362.86%

Managers

Managers TitleAgeSince
Director of Finance/CFO - 01/86/01
President 64 01/85/01
Chief Tech/Sci/R&D Officer 62 01/10/01
Chief Tech/Sci/R&D Officer 57 01/94/01
Compliance Officer 64 01/84/01
Chief Tech/Sci/R&D Officer 52 01/18/01
Director/Board Member 66 01/08/01
Comptroller/Controller/Auditor 61 01/19/01
Comptroller/Controller/Auditor 61 01/12/01
Human Resources Officer - 01/83/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 01/21/01
Director/Board Member 68 01/22/01
Director/Board Member 66 01/08/01
Director/Board Member 65 01/21/01
President 64 01/85/01
Compliance Officer 64 01/84/01
Director/Board Member 73 01/19/01
Director/Board Member 68 01/19/01
Director/Board Member 68 01/23/01
Chief Tech/Sci/R&D Officer 62 01/10/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 540,000,000 247,790,788 ( 45.89 %) 4,955,614 ( 0.9177 %) 45.89 %

Shareholders

NameEquities%Valuation
288,819,000 53.49 % 4 862 M €
6,986,280 1.294 % 118 M €
Goldman Sachs Asset Management Co., Ltd. (Japan)
0.9724 %
5,250,899 0.9724 % 88 M €
2,920,000 0.5407 % 49 M €
Lyxor International Asset Management SAS
0.1458 %
787,437 0.1458 % 13 M €
I. G. Investment Management Ltd.
0.1045 %
564,200 0.1045 % 9 M €
Kewpie Pension Fund
0.0880 %
475,000 0.0880 % 8 M €
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.0869 %
469,500 0.0869 % 8 M €
Sjunde AP-fonden
0.0859 %
463,600 0.0859 % 8 M €
Metzler Asset Management GmbH
0.0647 %
349,185 0.0647 % 6 M €

Holdings

NameEquities%Valuation
6,986,280 1.29% 117,603,405 $
2,873,563 1.23% 18,132,183 $
52,000 0.21% 283,189 $

Company contact information

Kyowa Kirin Co., Ltd.

Otemachi Financial City Grand Cube 1-9-2 Otemachi

100-0004, Tokyo

+81 3 5205 7200

http://www.kyowa-kirin.co.jp
address Kyowa Hakko Kirin Co Ltd
  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. Stock
  5. Company Kyowa Hakko Kirin Co Ltd
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW